Nalini A, Thennarasu K, Gourie-Devi M, Shenoy Sandhya, Kulshreshtha Dinkar
Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India.
J Neurol Sci. 2008 Sep 15;272(1-2):60-70. doi: 10.1016/j.jns.2008.04.034. Epub 2008 Jun 12.
Amyotrophic Lateral Sclerosis is a progressive disease causing degeneration of upper and lower motor neurons with an average survival of 2 to 3 years. We retrospectively analyzed 1,153 patients of classical sporadic ALS seen over 30 years for the clinical manifestations and survival pattern. There were 855 (74.2%) men and 298 (25.8%) women with a M:F ratio of 3:1. The mean age of onset was 46.2+/-14.1 years (18-85) and the mean duration of illness at evaluation was 17.7+/-20.7 months (0.5-180). Mean age of onset for bulbar onset group was 52.8+/-11.6 and for limb onset was 43.7+/-14.1 (p<0.0001). One third of patients had onset before 40 years of age. The overall median survival duration (MSD) was 114.8+/-25.9(SE) months (3.3-194.4). Survival did not differ between the men [101.7+/-27.4(SE)] and women [118.9+/-6.3(SE)]. Information on death was available in 124 patients. The mean age at death was 52.95 years (25.7-82.6). The MSD for bulbar onset group was 55.9+/-2.9(SE) months and for limb onset group 177.9+/-3.2(SE) (p<0.0001). Gender did not have an effect on the survival period. The clinical manifestations are similar to findings from other developing countries with regards to age of onset, sex ratio and survival. When compared to studies among Caucasians the age of onset was one to two decades earlier and the male preponderance was more. The survival pattern is close to those reported from developing countries particularly from Africa and among Asian immigrants to the West, while it is significantly longer compared to Caucasians who generally have a dismal prognosis. Thus, Indians appear to have a relatively younger age of onset and prolonged survival suggesting the relatively slow course of ALS among Indian patients.
肌萎缩侧索硬化症是一种进行性疾病,会导致上下运动神经元退化,平均生存期为2至3年。我们回顾性分析了30年间诊治的1153例典型散发性肌萎缩侧索硬化症患者的临床表现和生存模式。其中男性855例(74.2%),女性298例(25.8%),男女比例为3:1。平均发病年龄为46.2±14.1岁(18 - 85岁),评估时的平均病程为17.7±20.7个月(0.5 - 180个月)。延髓起病组的平均发病年龄为52.8±11.6岁,肢体起病组为43.7±14.1岁(p<0.0001)。三分之一的患者在40岁之前发病。总体中位生存期(MSD)为114.8±25.9(SE)个月(3.3 - 194.4个月)。男性[101.7±27.4(SE)]和女性[118.9±6.3(SE)]的生存期无差异。124例患者有死亡信息。平均死亡年龄为52.95岁(25.7 - 82.6岁)。延髓起病组的MSD为55.9±2.9(SE)个月,肢体起病组为177.9±3.2(SE)个月(p<0.0001)。性别对生存期无影响。在发病年龄、性别比例和生存期方面,临床表现与其他发展中国家的研究结果相似。与高加索人的研究相比,发病年龄早一到二十年,男性占比更多。生存模式与发展中国家(特别是非洲以及亚洲移民到西方的人群)报道的相近,而与通常预后较差的高加索人相比,生存期明显更长。因此,印度患者的发病年龄似乎相对较小,生存期延长,这表明印度患者的肌萎缩侧索硬化症病程相对较慢。